[
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148139"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Oral Moisturizing Jelly"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148139",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An edible, gel-based formulation containing an artificial saliva substitute, composed of water, electrolytes and buffering agents, with potential anti-xerostomia and protective activities. Upon application of the oral moisturizing jelly (OMJ), the natural electrolyte and pH balance of human saliva is restored, which increases moisture of mucosal tissues of the mouth, tongue and oropharynx. This relieves dryness, enhances lubrication, and increases salivary flow. OMJ makes it easier to chew, swallow and talk, and also prevents xerostomia-induced infections, as well as tooth decay."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C26170",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C26170",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C26170",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C26170",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C14814"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "NJS Mouse"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C14814",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148140"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Karonudib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148140",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally available inhibitor of Karolinska nudt1 (MTH1; MutT homologue 1; NUDT1), with potential antineoplastic activity. Upon administration, karonudib targets and binds to the active site of MTH1, thereby preventing the activity of MTH1. This leads to the incorporation of oxidized deoxynucleoside triphosphates (dNTPs) into the DNA of cancer cells, which causes DNA damage, introduces double strand breaks (DSBs), and induces apoptosis in cancer cells. MTH1, a member of the Nudix phosphohydrolase superfamily hydrolyzes oxidized purine nucleoside triphosphates, including 8-oxo-dGTP and 2-OH-dATP, converts them into their corresponding monophosphate forms, and prevents their incorporation into DNA, which allows MTH1-expressing cells to evade cell death. Compared to normal, healthy cells, cancer cells overexpress MTH1, which leads to dysregulation of the cellular redox system and increased reactive oxygen species (ROS) production, which together prevents the incorporation of damaged and oxidized nucleotides into DNA."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C129825",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C129825",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148141"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Tepoditamab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148141",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An immunoglobulin G1 (IgG1) bispecific human monoclonal antibody against human CD3, a T-cell surface antigen, and human C-type lectin domain family 12 member A (CLEC12A), a tumor-associated antigen (TAA) overexpressed on certain tumor cells, with potential antineoplastic activity. Upon administration, tepoditamab binds to both CD3 on T-cells and CLEC12A expressed on malignant cells, such as myeloid blasts, atypical progenitor cells and leukemic stem cells (LSCs). This results in the cross-linking of T-cells with tumor cells, and induces a potent cytotoxic T-lymphocyte (CTL) response against CLEC12A-expressing tumor cells. CLEC12A, a myeloid differentiation antigen and member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily, is overexpressed on myeloid leukemia cells, but not on normal early hematopoietic progenitors, including hematopoietic stem cells (HSCs)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C201282"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C201282"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C201282",
      "http://purl.obolibrary.org/obo/NCIT_C203828",
      "http://purl.obolibrary.org/obo/NCIT_C112883",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C28227",
      "http://purl.obolibrary.org/obo/NCIT_C1454"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C201282",
      "http://purl.obolibrary.org/obo/NCIT_C203828",
      "http://purl.obolibrary.org/obo/NCIT_C112883",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C28227",
      "http://purl.obolibrary.org/obo/NCIT_C1454"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148142"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Adenoviral PSA Vaccine ETBX-071"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148142",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine composed of a genetically engineered, replication-deficient adenovirus carrying the gene encoding human prostate-specific antigen (PSA), with potential immunostimulating and antineoplastic activities. Upon vaccination with the adenoviral-PSA vaccine ETBX-071, the adenovirus infects cells and expresses PSA. In turn, PSA activates the immune system and induces a cytotoxic T-lymphocyte (CTL) response against PSA-expressing tumor cells. PSA, a tumor associated antigen (TAA), is expressed by prostate epithelial cells and is overexpressed in prostate cancer."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C49146"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C49146"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C49146",
      "http://purl.obolibrary.org/obo/NCIT_C1572",
      "http://purl.obolibrary.org/obo/NCIT_C96404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C49146",
      "http://purl.obolibrary.org/obo/NCIT_C1572",
      "http://purl.obolibrary.org/obo/NCIT_C96404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148143"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Resiquimod Gel CD11301"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148143",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A topical gel containing the Toll-like receptor (TLR) agonist resiquimod, an imidazoquinolinamine, with potential immunomodulating activity. Upon topical application, the resiquimod gel CD11301 binds to TLR7 and 8, which are found mainly on dendritic cells (DCs), macrophages, and B-lymphocytes, and activates the TLR signaling pathway, which results in the induction of the nuclear translocation of transcription activator nuclear factor kappa-B (NF-kB) and activation of other transcription factors. Subsequently, NF-kB-dependent gene expression is induced and cytokine production increases, especially interferon-alpha (INF-a), which results in the enhancement of T-helper 1 (Th1) immune responses. In addition, topical application of resiquimod appears to activate epidermal Langerhans cells, leading to enhanced activation of T-lymphocytes."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C308",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C308",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148144"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Oral Therapeutic Vaccine V3-X"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148144",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable therapeutic vaccine consisting of the tumor-associated antigen (TAA) oligosaccharide antigen sialyl Lewis A (CA19-9; sialylated Lewis A antigen; carbohydrate antigen 19-9; cancer antigen 19-9), with potential immunostimulating and antineoplastic activities. Upon oral administration, oral therapeutic vaccine V3-X induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing CA19-9. CA19-9 is an antigen that is overexpressed in a variety of cancer cell types, and plays a key role in tumor cell survival and metastasis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1663",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1663",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148145"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Lutetium Lu 177 Vipivotide Tetraxetan"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148145",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioconjugate composed of PSMA-617, a human prostate-specific membrane antigen (PSMA)-targeting ligand, conjugated to the beta-emitting radioisotope lutetium Lu 177 (177Lu), with potential antineoplastic activity against PSMA-expressing tumor cells. Upon intravenous administration of lutetium Lu 177  vipivotide tetraxetan, vipivotide tetraxetan targets and binds to PSMA-expressing tumor cells. Upon binding, PSMA-expressing tumor cells are destroyed by 177Lu through the specific delivery of beta particle radiation. PSMA, a tumor-associated antigen and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148146"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PD-L1 Peptide Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148146",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A vaccine composed of a peptide derived from the tumor-associated antigen (TAA) and immune checkpoint molecule programmed cell death-1 ligand 1 (PD-L1) combined with the immunoadjuvant montanide ISA-51, with potential immunomodulating and antineoplastic activities. Vaccination with PD-L1 peptide vaccine may activate the immune system to induce an immune response against PD-L1-expressing cells. This may increase and restore the proliferation and activation of various immune cells, including cytotoxic T-lymphocytes (CTLs), and may eradicate PD-L1-expressing tumor cells. PD-L1 is overexpressed on many human cancer cell types as well as on antigen presenting cells (APCs) and immunosuppressive cells in the tumor micro-environment (TME), such as regulatory T-cells (Tregs). PD-L1 binding to its cognate receptor programmed cell death protein 1 (PD-1; PDCD1; CD279) on T-cells suppresses the immune system and results in increased immune evasion and decreased CTL activation. Montanide ISA-51, also known as incomplete Freund's adjuvant or IFA, is a stabilized water-in-oil emulsion adjuvant containing mineral oil with mannide oleate added as a surfactant that non-specifically stimulates cell-mediated immune responses to antigens."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148147"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Lazertinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148147",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally available third-generation, selective inhibitor of certain forms of the epidermal growth factor receptor (EGFR) with activating mutations, including the resistance mutation T790M, exon 19 deletions (Del19), and the L858R mutation, with potential antineoplastic activity. Upon administration, lazertinib specifically and irreversibly binds to and inhibits selective EGFR mutants, which prevents EGFR mutant-mediated signaling and leads to cell death in EGFR mutant-expressing tumor cells. Lazertinib may inhibit programmed cell death-1 ligand 1 (PD-L1) and inflammatory cytokines in specific cancer cells harboring certain EGFR mutations. Compared to some other EGFR inhibitors, lazertinib may have therapeutic benefits in tumors with T790M- or L858R-mediated drug resistance. In addition, lazertinib penetrates the blood-brain barrier (BBB). This agent shows minimal activity against wild-type EGFR (wtEGFR), and does not cause dose-limiting toxicities, which occur during the use of non-selective EGFR inhibitors and inhibit wtEGFR. EGFR, a receptor tyrosine kinase (RTK) mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C2167"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C2167"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C2167",
      "http://purl.obolibrary.org/obo/NCIT_C163952",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C2167",
      "http://purl.obolibrary.org/obo/NCIT_C163952",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148148"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Lactobacillus reuteri Probiotic Tablet"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148148",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A tablet containing a strain of the probiotic Gram-positive, naturally-occurring bacterium Lactobacillus reuteri (L. reuteri), with potential antimicrobial, immunomodulatory and protective activities. Upon oral administration of the L. reuteri probiotic tablet, the Lactobacillus strain may improve digestion and help maintain adequate colonization of the gastrointestinal (GI) tract by modulating the composition of the normal microflora. During colonization of the GI tract, this bacterium adheres to human intestinal epithelial cells, and activates intestinal epithelial proliferation; both of these processes promote the formation and maintenance of a protective barrier, thereby preventing the attachment of harmful pathogens. L. reuteri produces lactic acid and other substances during fermentation, and creates an acidic environment that is unfavorable for pathogens, thereby further protecting the intestinal mucosa against pathogen-induced damage and loss of integrity of the intestinal mucosal barrier. Dietary supplementation with this bacterium has been shown to decrease intestinal inflammation and enhance innate and acquired immunity. Lactobacillus reuteri is naturally found in the GI tract."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1505",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1505",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148149"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Allogeneic TCR alpha/beta-positive T-lymphocyte-depleted Peripheral Blood Stem Cells"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148149",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A preparation of allogeneic T-cell receptor (TCR) alpha/beta-positive T cell-depleted peripheral blood stem cells (PBSCs), that can potentially be used for hematopoietic stem cell transplantation (HSCT). Allogeneic PBMCs are processed, using the proprietary CliniMACS device, to remove TCRalpha/beta T-cells, while retaining other cells, such as donor-derived natural killer (NK) cells and gamma/delta T-cells. As TCR alpha/beta-positive T-cells appear to be related to the development of graft versus host disease (GvHD), depletion of these cells may lower the risk of the recipient developing GvHD. Upon infusion of the TCR alpha/beta-positive T-cell-depleted PBSCs for allogeneic stem cell transplantation (allo SCT), the alpha/beta-positive T-cell depletion as well as the presence of allogeneic NK cells, and other cells, may facilitate engraftment, exert graft-versus-leukemia effects, enhance post-transplant immune recovery, and reduce the risk of infections and GvHD."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C201557",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C201557",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201557",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201557",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C14815"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Developed from Crosses of CBA, A/HeNga, Dd, and NC/Nga"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C14815",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148150"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Autologous NY-ESO-1 TCR-targeted T Lymphocytes"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148150",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A preparation of human autologous T-lymphocytes that are transduced with a gene encoding a T-cell receptor (TCR) specific for the cancer-testis antigen NY-ESO-1, with potential immunostimulating and antineoplastic activities. Upon isolation, transduction, expansion ex vivo, and reintroduction into the patient, the anti-NY-ESO-1 TCR-transduced autologous T-cells recognize and bind to NY-ESO-1-overexpressing tumor cells. This may result in a specific cytotoxic T-lymphocyte (CTL)-mediated killing of NY-ESO-1-positive tumor cells. NY-ESO-1, a tumor-associated antigen (TAA), is found in normal testis and on the surface of various tumor cell types, and is not, or is minimally, expressed in normal, healthy cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C138180",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C138180",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C138180",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C138180",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148151"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Child-Pugh A-B7 Cirrhosis"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148151",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An indication that Child-Pugh scores ranging from A (scores 5 or 6) to B7 (score 7) for liver cirrhosis will be considered for trial inclusion."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C121007",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C121007",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C121007",
      "http://purl.obolibrary.org/obo/NCIT_C118969",
      "http://purl.obolibrary.org/obo/NCIT_C20993",
      "http://purl.obolibrary.org/obo/NCIT_C18742",
      "http://purl.obolibrary.org/obo/NCIT_C18020",
      "http://purl.obolibrary.org/obo/NCIT_C25218",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C121007",
      "http://purl.obolibrary.org/obo/NCIT_C118969",
      "http://purl.obolibrary.org/obo/NCIT_C20993",
      "http://purl.obolibrary.org/obo/NCIT_C18742",
      "http://purl.obolibrary.org/obo/NCIT_C18020",
      "http://purl.obolibrary.org/obo/NCIT_C25218",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148152"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Refractory Head and Neck Squamous Cell Carcinoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148152",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A head and neck squamous cell carcinoma that does not respond to treatment."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C151907",
      "http://purl.obolibrary.org/obo/NCIT_C171605",
      "http://purl.obolibrary.org/obo/NCIT_C34447"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C151907",
      "http://purl.obolibrary.org/obo/NCIT_C171605",
      "http://purl.obolibrary.org/obo/NCIT_C34447"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C151907",
      "http://purl.obolibrary.org/obo/NCIT_C152078",
      "http://purl.obolibrary.org/obo/NCIT_C120186",
      "http://purl.obolibrary.org/obo/NCIT_C7628",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C4013",
      "http://purl.obolibrary.org/obo/NCIT_C3077",
      "http://purl.obolibrary.org/obo/NCIT_C27571",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C35850",
      "http://purl.obolibrary.org/obo/NCIT_C2916",
      "http://purl.obolibrary.org/obo/NCIT_C3709",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C8511",
      "http://purl.obolibrary.org/obo/NCIT_C171605",
      "http://purl.obolibrary.org/obo/NCIT_C2929",
      "http://purl.obolibrary.org/obo/NCIT_C3792",
      "http://purl.obolibrary.org/obo/NCIT_C34447"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C151907",
      "http://purl.obolibrary.org/obo/NCIT_C152078",
      "http://purl.obolibrary.org/obo/NCIT_C120186",
      "http://purl.obolibrary.org/obo/NCIT_C7628",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C4013",
      "http://purl.obolibrary.org/obo/NCIT_C3077",
      "http://purl.obolibrary.org/obo/NCIT_C27571",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C35850",
      "http://purl.obolibrary.org/obo/NCIT_C2916",
      "http://purl.obolibrary.org/obo/NCIT_C3709",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C8511",
      "http://purl.obolibrary.org/obo/NCIT_C171605",
      "http://purl.obolibrary.org/obo/NCIT_C2929",
      "http://purl.obolibrary.org/obo/NCIT_C3792",
      "http://purl.obolibrary.org/obo/NCIT_C34447"
    ],
    "hasDirectChildren": true,
    "numDescendants": 7,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 7,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148153"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Metastatic Head and Neck Squamous Cell Carcinoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148153",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A head and neck squamous cell carcinoma which has spread from the original site of growth to another anatomic site."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C126465",
      "http://purl.obolibrary.org/obo/NCIT_C34447",
      "http://purl.obolibrary.org/obo/NCIT_C4104"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C126465",
      "http://purl.obolibrary.org/obo/NCIT_C34447",
      "http://purl.obolibrary.org/obo/NCIT_C4104"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C126465",
      "http://purl.obolibrary.org/obo/NCIT_C170467",
      "http://purl.obolibrary.org/obo/NCIT_C36263",
      "http://purl.obolibrary.org/obo/NCIT_C3261",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C4968",
      "http://purl.obolibrary.org/obo/NCIT_C36255",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C4013",
      "http://purl.obolibrary.org/obo/NCIT_C3077",
      "http://purl.obolibrary.org/obo/NCIT_C27571",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3482",
      "http://purl.obolibrary.org/obo/NCIT_C36310",
      "http://purl.obolibrary.org/obo/NCIT_C2916",
      "http://purl.obolibrary.org/obo/NCIT_C3709",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C35850",
      "http://purl.obolibrary.org/obo/NCIT_C34447",
      "http://purl.obolibrary.org/obo/NCIT_C2929",
      "http://purl.obolibrary.org/obo/NCIT_C3792",
      "http://purl.obolibrary.org/obo/NCIT_C4104"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C126465",
      "http://purl.obolibrary.org/obo/NCIT_C170467",
      "http://purl.obolibrary.org/obo/NCIT_C36263",
      "http://purl.obolibrary.org/obo/NCIT_C3261",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C4968",
      "http://purl.obolibrary.org/obo/NCIT_C36255",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C4013",
      "http://purl.obolibrary.org/obo/NCIT_C3077",
      "http://purl.obolibrary.org/obo/NCIT_C27571",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3482",
      "http://purl.obolibrary.org/obo/NCIT_C36310",
      "http://purl.obolibrary.org/obo/NCIT_C2916",
      "http://purl.obolibrary.org/obo/NCIT_C3709",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C35850",
      "http://purl.obolibrary.org/obo/NCIT_C34447",
      "http://purl.obolibrary.org/obo/NCIT_C2929",
      "http://purl.obolibrary.org/obo/NCIT_C3792",
      "http://purl.obolibrary.org/obo/NCIT_C4104"
    ],
    "hasDirectChildren": true,
    "numDescendants": 35,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 35,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148154"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PD-L1/IDO Peptide Vaccine IO102-103"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148154",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A peptide vaccine composed of IO103, a peptide vaccine derived from the tumor-associated antigen (TAA) programmed cell death-1 ligand 1 (PD-L1), IO102, the 21-mer peptide vaccine derived from the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO), and the immunoadjuvant montanide ISA-51, with potential immunomodulating and antineoplastic activities. Vaccination with the PD-L1/IDO peptide vaccine IO102-103 may activate the immune system to induce an immune response against PD-L1 and IDO-expressing cells. This may increase and restore the proliferation and activation of various immune cells, including cytotoxic T-lymphocytes (CTLs), and may eradicate PD-L1 and IDO-expressing tumor cells through a CTL-mediated immune response. PD-L1 is overexpressed on many human cancer cell types. PD-L1 binding to its cognate receptor programmed cell death protein 1 (PD-1; PDCD1; CD279) on T-cells suppresses the immune system and results in increased immune evasion and decreased CTL activation. IDO, a cytosolic enzyme responsible for tryptophan catabolism and conversion of tryptophan into kynurenine, is overexpressed by a variety of tumor cell types and antigen presenting cells (APCs) and plays an important role in immunosuppression mainly through suppression of CTL activation; tryptophan depletion inhibits T-lymphocyte proliferation and activation, and suppresses the immune system. Montanide ISA-51, also known as incomplete Freund's adjuvant or IFA, is a stabilized water-in-oil emulsion adjuvant containing mineral oil with mannide oleate added as a surfactant that non-specifically stimulates cell-mediated immune responses to antigens."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148155"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Prolgolimab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148155",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A monoclonal antibody directed against the negative immunoregulatory human cell receptor programmed cell death protein 1 (PD-1; PDCD1; CD279), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, prolgolimab binds to and inhibits PD-1 and its downstream signaling pathways. This may restore immune function through the activation of T-cells and cell-mediated immune responses against tumor cells. PD-1, a transmembrane protein in the immunoglobulin superfamily (IgSF) expressed on T-cells, functions as an immune checkpoint that negatively regulates T-cell activation and effector function when activated by its ligands programmed cell death-1 ligand 1 (PD-L1) or 2 (PD-L2); it plays an important role in tumor evasion from host immunity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C128037",
      "http://purl.obolibrary.org/obo/NCIT_C129822"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C128037",
      "http://purl.obolibrary.org/obo/NCIT_C129822"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C128037",
      "http://purl.obolibrary.org/obo/NCIT_C124946",
      "http://purl.obolibrary.org/obo/NCIT_C143250",
      "http://purl.obolibrary.org/obo/NCIT_C141144",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C128037",
      "http://purl.obolibrary.org/obo/NCIT_C124946",
      "http://purl.obolibrary.org/obo/NCIT_C143250",
      "http://purl.obolibrary.org/obo/NCIT_C141144",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148156"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Autologous CD19CAR-CD28-CD137/CD27/CD3zeta-iCasp9-expressing T-lymphocytes"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148156",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Autologous T-lymphocytes that have been transduced with a fourth generation-lentiviral vector to express the 4SCAR19 gene composed of a chimeric antigen receptor (CAR) consisting of a single chain variable fragment (scFv) of anti-CD19 coupled to the co-stimulatory molecules CD28, 4-1BB (CD137), and CD27, and to the cytoplasmic portion of the zeta chain of the human T-cell receptor (CD3zeta), and containing the apoptosis-inducible suicide gene human caspase 9 (iCASP9 or iC9), that is linked to a drug binding domain, with potential immunostimulating and antineoplastic activities. The iCASP9 construct consists of the entire coding sequence for the human FK506-drug binding protein (FKBP12) with an F36V mutation (FKBP12-F36V) that is linked to the gene encoding iC9, which is a modified form of the CASP9 gene where the sequences encoding the endogenous caspase activation and recruitment domains have been deleted. Upon transfusion, anti-CD19-CAR-CD28/CD137/CD27/CD3zeta-iCasp9-expressing autologous T-lymphocytes target and bind to CD19-expressing neoplastic B-cells. This results in a cytotoxic T-lymphocyte (CTL) response against CD19-expressing tumor cells, and causes tumor cell lysis. If the administered T-cells cause unacceptable side effects, the chemical homodimerizer AP1903, which binds to the FKBP12-F36V drug-binding domain, can be administered; this induces caspase 9 expression, and results in apoptosis of the administered 4SCAR19 T-cells. CD19, cluster of differentiation 19, is a B-cell-specific cell surface antigen overexpressed in B-cell lineage tumors. Incorporation of the costimulatory signaling domains increases human T-cell function, expansion, and survival."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C176018",
      "http://purl.obolibrary.org/obo/NCIT_C200766"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C176018",
      "http://purl.obolibrary.org/obo/NCIT_C200766"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C176018",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C176018",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148157"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "HDAC Inhibitor CKD-581"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148157",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A highly water-soluble, pan histone deacetylase (HDAC) inhibitor, with potential antineoplastic activity. Upon administration, HDAC inhibitor CKD-581 targets and inhibits HDAC, resulting in an accumulation of highly acetylated histones, the induction of chromatin remodeling, and an altered pattern of gene expression. This leads to the inhibition of tumor oncogene transcription, and the selective transcription of tumor suppressor genes, which results in the inhibition of tumor cell division and the induction of tumor cell apoptosis. HDACs, upregulated in many tumor cell types, are a family of metalloenzymes responsible for the deacetylation of chromatin histone proteins."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C1946"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C1946"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1946",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1946",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148158"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "RET/BRAF Multikinase Inhibitor RXDX-105"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148158",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C167277",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C167277",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C167277",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C167277",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148159"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Geptanolimab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148159",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An immunoglobulin G4 (IgG4) humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1; PD1; PDCD1; CD279), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, geptanolimab binds to and inhibits PD-1 and its downstream signaling pathways. This may restore immune function through the activation of T-cells and cell-mediated immune responses against tumor cells. PD-1, a transmembrane protein in the immunoglobulin superfamily (IgSF) expressed on T-cells, functions as an immune checkpoint that negatively regulates T-cell activation and effector function when activated by its ligands programmed cell death-1 ligand 1 (PD-L1) or 2 (PD-L2); it plays an important role in tumor evasion from host immunity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C128037",
      "http://purl.obolibrary.org/obo/NCIT_C129822"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C128037",
      "http://purl.obolibrary.org/obo/NCIT_C129822"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C128037",
      "http://purl.obolibrary.org/obo/NCIT_C124946",
      "http://purl.obolibrary.org/obo/NCIT_C143250",
      "http://purl.obolibrary.org/obo/NCIT_C141144",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C128037",
      "http://purl.obolibrary.org/obo/NCIT_C124946",
      "http://purl.obolibrary.org/obo/NCIT_C143250",
      "http://purl.obolibrary.org/obo/NCIT_C141144",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C14816"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "KYF/Ms Mouse"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C14816",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148160"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Autologous Mesothelin-specific CAR-T Cells"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148160",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Genetically modified, autologous T-lymphocytes transduced with a gene encoding a chimeric antigen receptor (CAR) specific for the human tumor-associated antigen (TAA) mesothelin, with potential immunomodulating and antineoplastic activities. After isolation, transduction, expansion in culture, and reintroduction into the patient, the autologous mesothelin-specific CAR-T cells specifically target and kill mesothelin-expressing tumor cells. Mesothelin, a cell surface glycoprotein involved in cell adhesion, is overexpressed in a variety of cancer cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C201275"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C201275"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C28681",
      "http://purl.obolibrary.org/obo/NCIT_C201275"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C28681",
      "http://purl.obolibrary.org/obo/NCIT_C201275"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148161"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Carbon C 14 Pevonedistat"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148161",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable radioconjugate composed of pevonedistat, a small molecule inhibitor of NEDD8-activating enzyme (NAE), radiolabeled with the radioisotope carbon C 14, with potential use for evaluating the pharmacokinetic profile of pevonedistat. Pevonedistat binds to and inhibits NAE, which results in the inhibition of tumor cell proliferation and survival. Labeling of pevonedistat with the radioactive tracer carbon C 14 allows for the evaluation of pevonedistat's pharmacokinetic profile, including its absorption, distribution, metabolism, and excretion (ADME)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148162"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Rituximab Conjugate CON-4619"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148162",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A proprietary conjugate of rituximab, a recombinant chimeric murine/human antibody directed against the CD20 antigen, with potential antineoplastic activity. Upon administration of the rituximab conjugate CON-4619, the rituximab moiety targets and binds to CD20, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C141215",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C141215",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C141215",
      "http://purl.obolibrary.org/obo/NCIT_C164034",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C141215",
      "http://purl.obolibrary.org/obo/NCIT_C164034",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148163"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Zirconium Zr 89 Anti-EGFR Monoclonal Antibody ABT-806"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148163",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioimmunoconjugate composed of ABT-806, a humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the epidermal growth factor receptor (EGFR), labeled with the radioisotope zirconium Zr 89, with potential use as an imaging agent upon positron emission tomography (PET). Upon administration of zirconium Zr 89 anti-EGFR monoclonal antibody ABT-806, the antibody moiety binds to a specific EGFR epitope of either the wild-type or the variant III mutant (EGFRvIII; de2-7 EGFR; DEGFR) on tumor cells. Upon PET imaging, EGFR-expressing tumor cells can be visualized and assessed. This may result in the quantification of EGFR-expressing tumor cells, an assessment of the expected response to treatment with ABT-806 and the selection of patients that would respond to ABT-806. ABT-806 is the humanized version of chimeric monoclonal antibody 806. EGFR, a receptor tyrosine kinase overexpressed on the cell surfaces of many tumor cell types, plays a key role in tumor cell proliferation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1511",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1511",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1511",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1511",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148164"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Autologous mRNA-modified Anti-cMET CAR-T Cells"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148164",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A preparation of autologous, genetically-engineered T-lymphocytes that have been electroporated with an mRNA encoding a chimeric antigen receptor (CAR) consisting of an anti-human hepatocyte growth factor receptor (HGFR or cMET) single chain variable fragment (scFv), with potential antineoplastic activities. Upon administration, autologous mRNA-modified anti-cMET CAR-T cells direct T-cells to cMET-expressing tumor cells, which induces selective toxicity against cMET-expressing tumor cells and causes tumor cell lysis. cMET, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C200766",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C200766",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148165"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Trastuzumab Conjugate BI-CON-02"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148165",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A conjugated form of trastuzumab, a humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2; ERBB2), with potential immunomodulating and antineoplastic activities. Upon administration, the trastuzumab conjugate BI-CON-02 targets and binds to HER2 on the tumor cell surface, thereby inducing both cytotoxic T-lymphocyte (CTL) and antibody-dependent cell-mediated cytotoxicity (ADCC) responses against tumor cells that overexpress HER2. HER2, a tyrosine kinase receptor, is overexpressed by many cancer cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C155712",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C155712",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155712",
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C163760",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155712",
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C163760",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148166"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Cyclin-dependent Kinase 8/19 Inhibitor BCD 115"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148166",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable inhibitor of cyclin dependent kinases 8 and 19 (CDK8/19), with potential antineoplastic and chemoprotective activities. Upon oral administration, CDK8/19 inhibitor BCD 115 binds to and inhibits the activity of CDK8/19, which prevents activation of CDK8/19-mediated oncogenic signaling pathways, blocks selective transcription of certain tumor promoting genes, and inhibits proliferation of CDK8/19-overexpressing tumor cells. CDKs are serine/threonine kinases involved in the regulation of the cell cycle and may be overexpressed in certain cancer cell types. CDK8 plays a key role in transcription regulation and is an important oncogenic driver in a variety of cancer cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2185",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2185",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2185",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2185",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148167"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Zirconium Zr 89 Pembrolizumab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148167",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioimmunoconjugate composed of pembrolizumab, a humanized monoclonal antibody immunoglobulin (Ig) G4 antibody directed against the human cell surface receptor programmed cell death 1 (PD-1; PDCD1; CD279; programmed cell death-1), labeled with the radioisotope zirconium Zr 89, with potential use as an imaging agent upon positron emission tomography (PET). Upon administration of zirconium Zr 89 pembrolizumab, the antibody moiety binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T-cells, and blocks the binding to and activation of PD-1 by its ligands. Upon PET imaging, PD-1-expressing T-cells, as well as pembrolizumab biodistribution, can be visualized and the expected response to treatment with pembrolizumab, as well as selection of patients that would respond to pembrolizumab, can be assessed. The ligands for PD-1 include programmed cell death-1 ligand 1 (PD-L1), which is overexpressed on certain cancer cells, and programmed cell death-1 ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1511",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1511",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1511",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1511",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148168"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Autologous EGFRt/BCMA-41BBz-targeted CAR T Cells"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148168",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A preparation of autologous T-lymphocytes transduced with a retroviral vector expressing a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) human B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17) fused to the co-stimulatory domain of 4-1BB (CD137) and the CD3-zeta (CD3z) T-cell signaling domain, and a truncated form of the human epidermal growth factor receptor (EGFRt), with potential immunostimulating and antineoplastic activities. Upon intravenous administration, autologous EGFRt/BCMA-41BBz-targeted CAR T cells are directed to, and induce selective toxicity in, BCMA-expressing tumor cells. Devoid of both ligand-binding domains and tyrosine kinase activity, the expressed EGFRt facilitates in vivo detection of the administered, transduced T-cells and, if the administered T-cells cause unacceptable side effects, can promote elimination of those cells through a cetuximab-induced antibody-dependent cellular cytotoxicity (ADCC) response. The 4-1BB costimulatory signaling domain enhances both proliferation of T-cells and antitumor activity. BCMA, a receptor for both a proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF), is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and plays a key role in plasma cell survival. BCMA is found on the surfaces of plasma cells and is overexpressed on malignant plasma cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C176023",
      "http://purl.obolibrary.org/obo/NCIT_C200766"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C176023",
      "http://purl.obolibrary.org/obo/NCIT_C200766"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C176023",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C176023",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148169"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fluorescein-conjugated Wisteria floribunda Lectin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148169",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A fluorescein conjugated to a preparation of lectin(s) extracted from the seeds of Wisteria floribunda (Japanese wisteria), with potential use as a diagnostic agent. Upon administration of fluorescein-conjugated Wisteria floribunda lectin, the lectin moiety preferentially targets and binds to carbohydrate structures containing N-acetylgalactosamine and galactose residues overexpressed on certain tumor cell surfaces. Using white and fluorescent light,  tumor cells with increased lectin-binding affinity can be visualized or imaged."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1966",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1966",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C14817"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "KYF/Hok Mouse"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C14817",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148170"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Raltitrexed Disodium"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148170",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The disodium salt form of raltitrexed, a quinazoline folate analogue, with potential antineoplastic activity.  Upon administration of raltitrexed, this agent is taken up by cells via the reduced folate carrier, undergoes intracellular polyglutamation, and blocks the folate-binding site of thymidylate synthase (TS). This inhibits the conversion of deoxyuridine monophosphate (dUMP) into deoxythymidine monophosphate (dTMP) and thus increases dUMP levels and decreases the amount of deoxythymidine triphosphate (dTTP) available for DNA synthesis. This prevents DNA replication and repair, and leads to DNA fragmentation and cell death, and results in reduced tumor cell 'proliferation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2021",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2021",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2021",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2021",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148171"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MUC1 SP Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148171",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A therapeutic cancer vaccine comprised of a synthetic, 21-mer long peptide (LP) derived from the entire signal peptide (SP) domain of the tumor-associated antigen (TAA) mucin 1 (MUC1), with potential immunomodulating and antineoplastic activities. Upon intradermal administration, MUC1 SP vaccine may stimulate the host immune system to mount robust cytotoxic T-lymphocyte (CTL) and B-cell responses against MUC1-expressing tumor cells, resulting in tumor cell apoptosis and decreased tumor growth. MUC1 is overexpressed on many tumor cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1663",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1752"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148172"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "SLCO1B3 Gene Positive"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148172",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An indication that the SLCO1B3 gene has been detected in a sample."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C103223",
      "http://purl.obolibrary.org/obo/NCIT_C35682"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C103223",
      "http://purl.obolibrary.org/obo/NCIT_C35682"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C103223",
      "http://purl.obolibrary.org/obo/NCIT_C36292",
      "http://purl.obolibrary.org/obo/NCIT_C77140",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C35682"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C103223",
      "http://purl.obolibrary.org/obo/NCIT_C36292",
      "http://purl.obolibrary.org/obo/NCIT_C77140",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C35682"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148173"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Refractory Thymic Carcinoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148173",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Thymic carcinoma that does not respond to treatment."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C7569",
      "http://purl.obolibrary.org/obo/NCIT_C8511"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C7569",
      "http://purl.obolibrary.org/obo/NCIT_C8511"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C7569",
      "http://purl.obolibrary.org/obo/NCIT_C2916",
      "http://purl.obolibrary.org/obo/NCIT_C3709",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C4962",
      "http://purl.obolibrary.org/obo/NCIT_C3412",
      "http://purl.obolibrary.org/obo/NCIT_C26962",
      "http://purl.obolibrary.org/obo/NCIT_C35742",
      "http://purl.obolibrary.org/obo/NCIT_C27669",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3406",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3576",
      "http://purl.obolibrary.org/obo/NCIT_C6450",
      "http://purl.obolibrary.org/obo/NCIT_C8511",
      "http://purl.obolibrary.org/obo/NCIT_C120186",
      "http://purl.obolibrary.org/obo/NCIT_C7628"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C7569",
      "http://purl.obolibrary.org/obo/NCIT_C2916",
      "http://purl.obolibrary.org/obo/NCIT_C3709",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C4962",
      "http://purl.obolibrary.org/obo/NCIT_C3412",
      "http://purl.obolibrary.org/obo/NCIT_C26962",
      "http://purl.obolibrary.org/obo/NCIT_C35742",
      "http://purl.obolibrary.org/obo/NCIT_C27669",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C3406",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3576",
      "http://purl.obolibrary.org/obo/NCIT_C6450",
      "http://purl.obolibrary.org/obo/NCIT_C8511",
      "http://purl.obolibrary.org/obo/NCIT_C120186",
      "http://purl.obolibrary.org/obo/NCIT_C7628"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148174"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Histone Gene"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148174",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A gene encoding a histone protein."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C20744",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C20744",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C20744",
      "http://purl.obolibrary.org/obo/NCIT_C16612"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C20744",
      "http://purl.obolibrary.org/obo/NCIT_C16612"
    ],
    "hasDirectChildren": true,
    "numDescendants": 170,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 170,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148175"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Refractory Indolent Adult Non-Hodgkin Lymphoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148175",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Indolent adult non-Hodgkin lymphoma that is resistant to treatment."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C173046",
      "http://purl.obolibrary.org/obo/NCIT_C8491"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C173046",
      "http://purl.obolibrary.org/obo/NCIT_C8491"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C173046",
      "http://purl.obolibrary.org/obo/NCIT_C8504",
      "http://purl.obolibrary.org/obo/NCIT_C7215",
      "http://purl.obolibrary.org/obo/NCIT_C3211",
      "http://purl.obolibrary.org/obo/NCIT_C3208",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C8701",
      "http://purl.obolibrary.org/obo/NCIT_C134154",
      "http://purl.obolibrary.org/obo/NCIT_C172280",
      "http://purl.obolibrary.org/obo/NCIT_C157686",
      "http://purl.obolibrary.org/obo/NCIT_C27357",
      "http://purl.obolibrary.org/obo/NCIT_C120186",
      "http://purl.obolibrary.org/obo/NCIT_C7628",
      "http://purl.obolibrary.org/obo/NCIT_C8491",
      "http://purl.obolibrary.org/obo/NCIT_C7704",
      "http://purl.obolibrary.org/obo/NCIT_C7587"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C173046",
      "http://purl.obolibrary.org/obo/NCIT_C8504",
      "http://purl.obolibrary.org/obo/NCIT_C7215",
      "http://purl.obolibrary.org/obo/NCIT_C3211",
      "http://purl.obolibrary.org/obo/NCIT_C3208",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C8701",
      "http://purl.obolibrary.org/obo/NCIT_C134154",
      "http://purl.obolibrary.org/obo/NCIT_C172280",
      "http://purl.obolibrary.org/obo/NCIT_C157686",
      "http://purl.obolibrary.org/obo/NCIT_C27357",
      "http://purl.obolibrary.org/obo/NCIT_C120186",
      "http://purl.obolibrary.org/obo/NCIT_C7628",
      "http://purl.obolibrary.org/obo/NCIT_C8491",
      "http://purl.obolibrary.org/obo/NCIT_C7704",
      "http://purl.obolibrary.org/obo/NCIT_C7587"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148176"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anti-BCMA Antibody SEA-BCMA"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148176",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A humanized, afucosylated monoclonal antibody created using the proprietary, sugar-engineered antibody (SEA) platform and directed against the tumor-associated antigen (TAA) human B-cell maturation antigen (BCMA; TNFRSF17), with potential immunoadjuvant activity. Upon administration, the anti-BCMA antibody SEA-BCMA targets and binds to BCMA expressed on tumor cells.  When administered with antibody-coupled T-cell receptor (ACTR)-expressing T-cells, the ACTR-expressing T-cells bind, with high affinity, to the anti-BCMA antibody SEA-BCMA. This activates the ACTR T-cells and the T-cells induce specific cytotoxic T-lymphocyte (CTL)-mediated cytotoxicity toward BCMA-expressing tumor cells. BCMA, a cell surface protein and member of the tumor necrosis factor (TNF) receptor superfamily that is specifically overexpressed on malignant plasma cells, plays a key role in promoting plasma cell survival."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C181113",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C181113",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C181113",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C181111",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C181113",
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C181111",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148177"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148177",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A preparation of an approximately equal ratio of autologous CD4- and CD8-positive T-lymphocytes that have been ex vivo transduced with a genetically-engineered self-inactivating (SIN) lentiviral vector (LV) expressing a chimeric antigen receptor (CAR) containing a single chain variable fragment (scFv) specific for the human tumor-associated antigen (TAA) B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17) fused to the co-stimulatory domain of 4-1BB (CD137), the CD3-zeta (CD3z) T-cell signaling domain, and a truncated form of the human epidermal growth factor receptor (EGFRt), with potential immunostimulating and antineoplastic activities. Upon administration, the autologous anti-BCMA-CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes specifically recognize and induce selective toxicity against BCMA-expressing tumor cells. Devoid of both ligand binding domains and tyrosine kinase activity, the expressed EGFRt facilitates both in vivo detection of the administered, transduced T-cells and can promote elimination of those cells through a cetuximab-induced antibody-dependent cellular cytotoxicity (ADCC) response. BCMA, a tumor-specific antigen and a receptor for both a proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF), is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and plays a key role in plasma cell survival. BCMA is found on the surfaces of plasma cells and is overexpressed on malignant plasma cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C176023",
      "http://purl.obolibrary.org/obo/NCIT_C200766"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C176023",
      "http://purl.obolibrary.org/obo/NCIT_C200766"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C176023",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C176023",
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C137999",
      "http://purl.obolibrary.org/obo/NCIT_C154231",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C200766",
      "http://purl.obolibrary.org/obo/NCIT_C28681"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148178"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Oncolytic Vaccinia Virus TG6002"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148178",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A modified, replicative oncolytic vaccinia virus (VV), deleted of the genes for tyrosine kinase (TK) and ribonucleotide reductase (RR), and expressing the yeast-originated, bifunctional cytosine deaminase/uracil phosphoribosyltransferase gene (FCU1), with potential immunomodulating and antineoplastic activities. Upon intravenous administration of the oncolytic vaccinia virus TG6002, the virus preferentially targets and infects tumor cells, causing oncolysis. In turn, the lysed tumor cells release various tumor-associated antigens (TAAs), which induce an immune response against the tumor cells. Upon concomitant administration of the non-cytotoxic prodrug flucytosine (5-fluorocytosine; 5-FC), the FCU1 expressed in the infected cancer cells produce the enzymes cytosine deaminase and uracil phosphoribosyltransferase which catalyze the conversion of 5-FC into the cytotoxic forms 5-fluorouracil (5-FU) and 5-fluoro-uridilyl monophosphate (5-FUMP); 5-FU and 5-FUMP exert a cytotoxic effect in the infected tumor cells. Double gene deletion (TK-RR-) restricts the propagation of TG6002 to the tumor cells, thereby reducing toxicity to normal cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C717"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C717"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C717",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C717",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148179"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Licochalcone A"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148179",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A derivative of the phenol chalconoid, found in and extracted from the roots of Glycyrrhiza species G. glabra and inflata, with potential anti-inflammatory, antibacterial, and anticancer activities. Upon administration, licochalcone A inhibits the phosphatidylinositol-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway and inhibits the activity of c-Jun N-terminal kinase 1 (JNK-1), a member of the mitogen-activated protein kinase (MAPK) family that plays a role in the MAPK-mediated signaling pathway. Inhibition of the PI3K/Akt/mTOR- and MAPK-signaling pathways induces cell cycle arrest and apoptosis, decreases migration and invasion of cancer cells, and inhibits tumor cell proliferation. Licochalcone A also prevents the production of reactive oxygen species (ROS), and reduces oxidative stress through the nuclear factor-erythroid 2-related factor 2 (Nrf2) pathway."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2189",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2189",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C14818"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Female Kunming Albino X Male 615"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C14818",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C83480",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C83480",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148180"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PD-1 knockout EBV-specific Cytotoxic T Lymphocytes"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148180",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A preparation of Epstein-Barr virus (EBV) reactive cytotoxic T-lymphocytes (CTLs) in which the programmed cell death 1 (PD-1; PDCD1; CD279; programmed death-1) gene is deleted, with potential immunomodulating activity. Upon administration of the PD-1 knockout EBV-specific CTLs, these CTLs target and induce selective toxicity in EBV-positive cancer cells. This results in cell lysis and inhibition of cancer cell proliferation. Expression of PD-1, an inhibitory receptor expressed on activated T-cells, plays a key role in CTL suppression, T-cell exhaustion and CTL apoptosis. PD-1 knockout abrogates T-cell exhaustion and increases T-cell activity and cytotoxicity. EBV, a ubiquitous human herpesvirus, is associated with various cancer cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C129826",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C129826",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148181"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Danicopan"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148181",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable inhibitor of complement factor D (FD; CFD), a serine protease that cleaves complement factor B, with potential complement system inhibiting activity. Upon administration, danicopan targets, binds to and blocks the activity of FD, and thereby inhibits cleavage of complement factor B into Ba and Bb in the alternative pathway of the complement cascade. This inhibits FD-mediated signaling and activation of the alternative complement pathway (ACP), blocks complement-mediated hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and prevents ACP-induced tissue damage. FD plays a key role in the activation of the ACP."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C308",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C308",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148182"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ruthenium-based Photosensitizer TLD1411"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148182",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A ruthenium-based photosensitizer (PS), that can potentially be used for photodynamic therapy (PDT). Upon intratumoral administration, the ruthenium-based PS TLD1411 targets mitochondria in tumor cells. Upon PDT, TLD1411 produces singlet molecular oxygen (O2), and induces a reactive oxygen species (ROS)-mediated tumor cell apoptosis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1420",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1420",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1420",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1420",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C148184"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Amorphous Calcium Carbonate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C148184",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A nutritional supplement composed of a proprietary synthetic and amorphous form of calcium carbonate, that can potentially be used to replenish calcium. Upon administration of amorphous calcium carbonate (ACC), the mineral calcium may give calcium supplementary support, improve bone, muscle and heart strength, improve performance and decrease bone-associated pain."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1505",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1505",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1505",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  }
]